Please login to the form below

Not currently logged in
Email:
Password:

United Drug

This page shows the latest United Drug news and features for those working in and with pharma, biotech and healthcare.

CHMP backs MSD’s CMV infection treatment

CHMP backs MSD’s CMV infection treatment

process as we hope to bring this product to patients in the United Kingdom.”. ... The US Food and Drug Administration approved letermovir once-daily tablets for oral use and injection for intravenous infusion earlier this month.

Latest news

  • FDA clears first therapy for rare childhood cancer FDA clears first therapy for rare childhood cancer

    FDA clears first therapy for rare childhood cancer. United Therapeutics’ Unituxin approved for neuroblastoma. ... United. The drug is also a first because it is the first approved therapy that targets a non-protein antigen on cancer cells.

  • UDG broadens Ashfield offering UDG broadens Ashfield offering

    The changes follow the rebranding of Ashfield's parent company from United Drug to UDG Healthcare in October 2013. ... The group has operations in 22 countries and operates across four key areas: Aquilant Specialist Healthcare Services, Ashfield

  • United Drug expands remit of Ashfield division

    United Drug expands remit of Ashfield division. And healthcare services provider rebrands to UDG Healthcare. ... The move comes as healthcare services provider United Drug restructures both its operations and branding, changing its name to UDG Healthcare.

  • Celesio sells off Movianto and Pharmexx

    Celesio sells off Movianto and Pharmexx. Owens &Minor buys Movianto while United Drug snaps up contract sales business. ... Meanwhile, Irish pharma services conglomerate United Drug has acquired the German contract sales and vacancy management company

  • United Drug acquires Watermeadow Medical

    We are delighted to announce the acquisition of Watermeadow,” said Liam FitzGerald, chief executive, United Drug. “ ... I'm delighted that Watermeadow will be joining the United Drug group,” said Watermeadow managing director, Paul Hilditch. “

More from news
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Applying real-world evidence to orphan drugs Applying real-world evidence to orphan drugs

    These include the United States 1983 Orphan Drug Act, which offers tax incentives, the Food and Drug Administration (FDA) Office of Orphan Products (OOPD) which promotes collaboration between multiple stakeholders by

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Indians scalp cowboys in patent war

    In the United States, the drug company Allergan has found an ingenious solution to the patent expiry issue. ... In America, tribal reservations are often dispiriting places, with high levels of unemployment, and health problems including alcoholism and

  • Watermeadow Medical

    Watermeadow is part of Ashfield Healthcare Communications (a United Drug company), giving our clients access to over 1100 medical communications specialists including extensive digital teams and offices around the globe.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics